Please assess the completion status of the following clinical trial:

Trial Title: A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients at risk of systemic fungal infections due to their immunocompromised state due to one of the following:~  * Patient with a hematologic malignancy undergoing an autologous hematopoietic stem cell transplant~ * Any patient undergoing an allogeneic hematopoietic stem cell transplant~Exclusion Criteria:~* Patients with moderate or severe liver disease, as defined by:~  * AST or ALT greater than 5 times upper limit of normal (ULN), OR;~ * Total bilirubin greater than 2.5 times ULN~* Patients with evidence of a deeply invasive or disseminated fungal infection at time of enrollment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1. Micafungin (Type: EXPERIMENTAL): None
- 2. Itraconazole (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).